CytomX Therapeutics, Inc. short interest in 2020
In 2020, CytomX Therapeutics, Inc.'s disclosed short interest ran from 3.39% of shares outstanding on 15 Jan 2020 to 6.27% on 31 Dec 2020, a change of +2.88 percentage points. The year's high was 8.55% on 30 Oct 2020 and its low 1.90% on 31 Mar 2020, averaging 5.11% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.38 days on 15 Oct 2020. Full history: CytomX Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 3.39% (15 Jan 2020)
- End of year
- 6.27% (31 Dec 2020)
- Change
- +2.88 pp
- High
- 8.55% (30 Oct 2020)
- Low
- 1.90% (31 Mar 2020)
- Average
- 5.11%
- Highest days to cover
- 12.38 (15 Oct 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 3.39% | 5.05 | |
| 31 Jan 2020 | 2.88% | 4.08 | |
| 14 Feb 2020 | 2.54% | 3.69 | |
| 28 Feb 2020 | 2.80% | 2.47 | 10-K filed, results (8-K) |
| 13 Mar 2020 | 3.12% | 3.06 | |
| 31 Mar 2020 | 1.90% | 1.74 | |
| 15 Apr 2020 | 2.74% | 2.89 | |
| 30 Apr 2020 | 2.33% | 2.16 | |
| 15 May 2020 | 2.56% | 1.32 | 10-Q filed, results (8-K) |
| 29 May 2020 | 2.61% | 1.84 | |
| 15 Jun 2020 | 3.67% | 2.65 | |
| 30 Jun 2020 | 6.91% | 4.79 | |
| 15 Jul 2020 | 5.81% | 6.98 | |
| 31 Jul 2020 | 6.98% | 8.43 | |
| 14 Aug 2020 | 7.19% | 9.38 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 7.61% | 11.06 | |
| 15 Sep 2020 | 7.15% | 6.56 | |
| 30 Sep 2020 | 6.64% | 7.76 | |
| 15 Oct 2020 | 7.36% | 12.38 | |
| 30 Oct 2020 | 8.55% | 9.57 | |
| 13 Nov 2020 | 7.93% | 10.21 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 7.12% | 11.18 | |
| 15 Dec 2020 | 6.50% | 6.17 | |
| 31 Dec 2020 | 6.27% | 4.34 |
See also: CytomX Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.